Picture of Rigel Pharmaceuticals logo

RIGL — Rigel Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Rigel Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

* Rigel Pharmaceuticals Inc  RIGL.OQ  reported quarterly
adjusted
earnings of 70 cents​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of -30 cents.  The mean expectation of six analysts
for the quarter was for earnings of 6 cents per share. Wall
Street expected results to range from -21 cents to 32 cents per
share.
    * Revenue rose 96.6% to $55.31 million from a year ago;
analysts
expected $41.93 million. 
    * Rigel Pharmaceuticals Inc's reported EPS for the quarter
was 70
cents​.
    * The company reported quarterly net income of $12.42
million.
    * Rigel Pharmaceuticals Inc shares had fallen by 6.8% this
quarter and gained 4.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is  "hold."

Wall Street's median 12-month price target for Rigel
Pharmaceuticals Inc is $16.00 
This summary was machine generated from LSEG data November 8 at
05:12 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.06           0.70           Beat
 Jun. 30 2024      -0.29          -0.06          Beat
 Mar. 31 2024      -0.29          -0.50          Missed
 Dec. 31 2023      -0.30          0.00           Beat

Recent news on Rigel Pharmaceuticals

See all news